Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immunic, Inc.

1.11
-0.0300-2.63%
Post-market: 1.120.0100+0.90%19:02 EDT
Volume:423.79K
Turnover:476.96K
Market Cap:106.36M
PE:-1.11
High:1.22
Open:1.17
Low:1.10
Close:1.14
Loading ...
Jul 24, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 24, 2019

Statement Of Changes In Beneficial Ownership

Initial statement of beneficial ownership of securities
Jul 17, 2019

Major Issues Report

Current report, items 1.01, 5.03, 8.01, and 9.01
Jul 17, 2019

Major Issues Report

Current report, items 1.01, 5.02, 5.07, and 9.01
Jun 21, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Jun 04, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Apr 29, 2019

Major Issues Report

Current report, items 5.02, 7.01, and 9.01
Apr 15, 2019

Major Issues Report

Current report, items 2.01, 3.03, 4.01, 5.01, 5.02, 5.03, 7.01, 8.01, and 9.01
Apr 10, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Apr 10, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Apr 04, 2019

Major Issues Report

Current report, items 5.07, 8.01, and 9.01
Apr 02, 2019

Business Combinations

Prospectuses and communications, business combinations
Mar 19, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Mar 14, 2019

Business Combinations

Prospectuses and communications, business combinations
Mar 04, 2019

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 04, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Feb 28, 2019

Business Combinations

Prospectuses and communications, business combinations
Feb 26, 2019

Business Combinations

Prospectuses and communications, business combinations
Feb 13, 2019

Correspondence

[Cover]Correspondence
Feb 06, 2019

Business Combinations

Prospectuses and communications, business combinations